Thriva raises £4M from Target in an era when at-home blood testing is more crucial than everThriva emerged in 2016 as an at-home blood-testing startup allowing people to check, for instance, cholesterol levels.
In the era of a pandemic, however, at-home blood testing is about to become quite a big deal, alongside the general trend toward people proactively taking control of their health.
It has secured a £4 million extension to its Series A funding round from Berlin-based VC Target Global .
Thriva has processed more than 115,000 at-home blood tests since 2016.
Our at-home blood tests are an important data point but they’re just the beginning of the long-term relationships we’re creating with our customers.

Comments to: Thriva raises £4M from Target in an era when at-home blood testing is more crucial than ever – TechCrunch

Your email address will not be published. Required fields are marked *

Attach images - Only PNG, JPG, JPEG and GIF are supported.

Login

Welcome to Typer

Brief and amiable onboarding is the first thing a new user sees in the theme.
Join Typer
Registration is closed.